Illumigyn Overview
Illumigyn develops technology in the field of gynecology, offering a comprehensive platform solution featuring the Gynescope System, an FDA-cleared gynecology endoscope and cloud platform service. The Illumigyn Gynescope System uses a novel technology that creates high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy. The images are uploaded to the cloud for viewing and analysis by any doctor across the globe. With Illumigyn, the patient has more control and a close view of the procedure, with immediate access to a second opinion by AI clinical decision support software, without undergoing another procedure. The company aims to use its technological know-how and expertise to create an ecosystem that will empower all facets of women's health, making it accessible and affordable for every woman worldwide.
Cumulative Funding Raised Over Time ($)
$5.0MNov 2016
$38.0MNov 2021
Latest News
growth-positive
Gynescope remote systems deployed to save African women
Illumigyns gynecological imaging platform, Gynescope, will be distributed across Africa to improve early diagnosis and detection rates of cervical cancer. Illumigyn and Peramare Enterprises signed a distribution agreement for 20,000 Gynescope units, aiming to ensure the early detection of cervical cancer in women in Africa. The system allows for high-resolution imaging of the cervix, vagina, and external genitalia, with the images uploaded to Illumigyns secure cloud for remote diagnostics and consultations. The deal was made possible with credit backing from Afreximbank, a pan-African multilateral trade finance institution. This initiative is expected to have significant health and socio-economic benefits for women in Africa.
CustomersPartners
growth-positive
illumigyn™ Partners with Peramare Enterprises Ltd. and Supported by Afreximbank to Deploy Its Cutting-Edge Gynecological Imaging System and Cloud-Based Platform throughout Africa
illumigyn has signed a distribution agreement with Peramare Enterprises to deploy 20,000 Gynescopes™ systems across Africa. The African Export-Import Bank will provide financial backing for the agreement. The World Health Organization states that cervical cancer is a significant public health threat in Africa, and illumigyn aims to combat this by providing accessible screenings and remote-diagnostics platforms. The Gynescopes™ system digitally documents the cervix, vagina, and external genitalia, enabling more accurate pap smears. The system can be operated by trained caregivers, allowing women in remote locations to be screened and diagnosed. The partnership between illumigyn, Peramare Enterprises, and Afreximbank aims to improve access to healthcare and save womens lives in Africa.
CustomersPartners
growth-positive
illumigyn raises $33 million to help women with affordable medical care
Illumigyn, a remote gynecological imaging platform, has raised $33 million in a funding round that included participation from the Yozma Group Korea and Ubicom Holdings Japan. The funding will be used to deploy its platform in the United States, United Arab Emirates, India, Singapore, and South Korea. The platform features the Gynescope System, a gynecology endoscope and cloud platform service with an accompanying mobile app that can digitally document the cervix, vagina, and external genitals. The investment will also support R&D efforts for the company to provide women across the world the best care for cancers and other diseases.
InvestmentExpand
growth-positive
Israeli women's health startup to deliver devices to Gulf
Israeli women’s health startup Illumigyn has signed a memorandum of understanding with Dubai-based company DHI2048 to deliver 2,500 high-tech speculums to the Gulf states. The deal is valued at an estimated $150 million. Illumigyns Gynescope device enables high-end imaging of the cervix, vagina, and external genitalia, allowing for remote diagnosis and reducing the need for invasive procedures. The partnership aims to revolutionize womens healthcare and establish Dubai as a healthcare hub for the region.
PartnersCustomers
growth-positive
illumigyn signs MoU to deploy 2,500 units of its "gynecology endoscope" cloud platform in UAE
Israeli company illumigyn has signed a Memorandum of Understanding with Dubai-based company DHI 2048 to deploy 2,500 units of its cloud-based gynecological imaging service. The partnership aims to improve womens healthcare in the region and make Dubai a healthcare hub. The Gynescope System provided by illumigyn offers an end-to-end gynecological imaging service, including image documentation, archiving, and sharing. The MoU was signed one year after the Abraham Accords, which marked the beginning of open economic relations between Israel and the UAE. The collaboration agreement between illumigyn and DHI 2048 is seen as a testament to the growing ties between the two countries.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $38M |
| Last funding | $33M |
| Stage | A |
| Rounds | 2 |
| Investors | 2 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.illumigyn.com |
Locations
Neve Ilan, Israel
Photos & Videos
3 item(s)
Illumigyn Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics DevicesTarget Customer
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProvidersCore Technology
Artificial IntelligenceSimulation & ImagingData StorageCloudTags (27)
femtechmedical-devicescolonoscopywomen-healthdoctorsimagingcancerdiagnosticsclinicshospitalshealthcare-providersgynecologypreventionearly-detectionnon-invasiveartificial-intelligencereal-timebiopsyoptronicsbig-datacloud-basedendoscopydigital-healthcarewomenmachine-visionremote-monitoringmedical-technologiesGeographic Markets
AfricaUnited Arab EmiratesIndiaIllumigyn Financials
$38M
Total funding
Undisclosed
Capital raised
$33M
Last funding
A
Funding stage
2
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
$5.0MNov 2016
$38.0MNov 2021
Private Equity Funding
A Round
Nov 2021
$33M
The Yozma Group (Lead)
,
Ubicom Holdings
Seed
Nov 2016
$5M
Illumigyn Lifecycle
Cumulative Funding Raised Over Time
$5.0MNov 2016
$38.0MNov 2021
All Events
A Round
Nov 2021
$33M
The Yozma Group (Lead)
,
Ubicom Holdings
Seed
Nov 2016
$5M
Illumigyn News
9 articles
growth-positive
Gynescope remote systems deployed to save African women
Illumigyns gynecological imaging platform, Gynescope, will be distributed across Africa to improve early diagnosis and detection rates of cervical cancer. Illumigyn and Peramare Enterprises signed a distribution agreement for 20,000 Gynescope units, aiming to ensure the early detection of cervical cancer in women in Africa. The system allows for high-resolution imaging of the cervix, vagina, and external genitalia, with the images uploaded to Illumigyns secure cloud for remote diagnostics and consultations. The deal was made possible with credit backing from Afreximbank, a pan-African multilateral trade finance institution. This initiative is expected to have significant health and socio-economic benefits for women in Africa.
CustomersPartners
growth-positive
illumigyn™ Partners with Peramare Enterprises Ltd. and Supported by Afreximbank to Deploy Its Cutting-Edge Gynecological Imaging System and Cloud-Based Platform throughout Africa
illumigyn has signed a distribution agreement with Peramare Enterprises to deploy 20,000 Gynescopes™ systems across Africa. The African Export-Import Bank will provide financial backing for the agreement. The World Health Organization states that cervical cancer is a significant public health threat in Africa, and illumigyn aims to combat this by providing accessible screenings and remote-diagnostics platforms. The Gynescopes™ system digitally documents the cervix, vagina, and external genitalia, enabling more accurate pap smears. The system can be operated by trained caregivers, allowing women in remote locations to be screened and diagnosed. The partnership between illumigyn, Peramare Enterprises, and Afreximbank aims to improve access to healthcare and save womens lives in Africa.
CustomersPartners
growth-positive
illumigyn raises $33 million to help women with affordable medical care
Illumigyn, a remote gynecological imaging platform, has raised $33 million in a funding round that included participation from the Yozma Group Korea and Ubicom Holdings Japan. The funding will be used to deploy its platform in the United States, United Arab Emirates, India, Singapore, and South Korea. The platform features the Gynescope System, a gynecology endoscope and cloud platform service with an accompanying mobile app that can digitally document the cervix, vagina, and external genitals. The investment will also support R&D efforts for the company to provide women across the world the best care for cancers and other diseases.
InvestmentExpand
growth-positive
Israeli women's health startup to deliver devices to Gulf
Israeli women’s health startup Illumigyn has signed a memorandum of understanding with Dubai-based company DHI2048 to deliver 2,500 high-tech speculums to the Gulf states. The deal is valued at an estimated $150 million. Illumigyns Gynescope device enables high-end imaging of the cervix, vagina, and external genitalia, allowing for remote diagnosis and reducing the need for invasive procedures. The partnership aims to revolutionize womens healthcare and establish Dubai as a healthcare hub for the region.
PartnersCustomers
growth-positive
illumigyn signs MoU to deploy 2,500 units of its "gynecology endoscope" cloud platform in UAE
Israeli company illumigyn has signed a Memorandum of Understanding with Dubai-based company DHI 2048 to deploy 2,500 units of its cloud-based gynecological imaging service. The partnership aims to improve womens healthcare in the region and make Dubai a healthcare hub. The Gynescope System provided by illumigyn offers an end-to-end gynecological imaging service, including image documentation, archiving, and sharing. The MoU was signed one year after the Abraham Accords, which marked the beginning of open economic relations between Israel and the UAE. The collaboration agreement between illumigyn and DHI 2048 is seen as a testament to the growing ties between the two countries.
Partners
growth-positive
Israel-Japan partners eye robot testers, autonomous forklifts on factory floor
Israeli tech entrepreneur Ran Poliakine, founder of Powermat Technologies, is partnering with Musashi Seimitsu Corporation, a unit of Honda Motor Co, to develop artificial intelligence technologies for the industrial manufacturing process. The partnership aims to bring AI and digitalization to the production line, focusing on quality assurance robots and autonomous forklifts. The collaboration is seen as beneficial for both companies and the industry as a whole. The partnership was announced during a visit of Japanese businesspeople to Israel, led by Japanese Minister of Economy Hiroshige Seko. Musashi Seimitsu Industry is listed on the Tokyo Stock Exchange with $2.3 billion in revenue and 16,000 employees in 12 countries.
Partners
growth-positive
Israeli co brings gynecology into the 21st century
Illumigyn, a startup founded by Ran Poliakine, is developing a new device to improve testing for cervical cancer. The device, called Gynescope, uses infrared and ultraviolet cameras to detect defects below the surface, such as cancerous cells. The device allows doctors to view images on a screen and save them for future comparison. Illumigyn plans to market the device for more accurate identification of biopsy sites and may later compete in the colposcope field. The company has received a $5 million investment from Poliakine, CEO Ariel Katz, and a group of private investors. Illumigyn is currently in the soft launch phase and expects to be approved and available within two years.
Customers
growth-positive
Israeli medical company hopes to save thousands of women's lives per year
Illumigyn, a medical technology company based in Jerusalem, is developing advanced imaging technology to improve the identification and treatment of cervical cancer and other diseases in women. The companys signature product, the Gynescope, is a compact imaging device that uses machine vision technologies to allow gynecologists to perform colposcopies, cervical exams, biopsies, and other procedures. Illumigyn aims to provide gynecologists with a new way of working, build an image database for each patient, suggest potential problems, and guide physicians through procedures. The company has received positive feedback from the field and is now focused on building a database with a sufficient number of images.
Customers
Illumigyn Introduces the Gynescope at ACOG
Illumigyn Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 21 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 15 classification IDs that could be used for matching.
Illumigyn Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514805985 |
| Crunchbase | illumigyn |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-09-13T00:00:00.000Z |
| Created | 2015-07-21T00:00:00.000Z |